首页|游离DNA在肝脏疾病中的应用进展

游离DNA在肝脏疾病中的应用进展

Advances in the use of free DNA in liver disease

扫码查看
体液活检与传统侵入性检查相比具有许多独特的优势,尤其在产前诊断、器官移植后免疫排异反应、肿瘤早期诊断和肝脏疾病诊疗方面展现出巨大潜力.在肝脏疾病领域,游离DNA参与机体内在的炎性反应和凝血过程.基于表观遗传学的研究,游离DNA片段的甲基化分析对肝脏恶性肿瘤的早期诊断和治疗大有帮助.在器官移植后,游离DNA有望成为监测免疫排异反应的重要标志物,为关于免疫排异反应机制的研究提供了新角度.文章对游离DNA的来源、提取方法、检测方法,以及其在肝移植、肝癌、肝衰竭等疾病中的研究应用进展进行综述.
Body fluid biopsy exhibits significant promise in prenatal diagnostics,post-organ transplantation immune rejection monitoring,early tumor detection,and liver diseases due to its distinct advantages over conventional invasive ex-aminations.In the realm of liver diseases,circulating-free DNA not only mirrors hepatic function but potentially participates in the pathophysiological cascades of inflammation and coagulation alterations.The unique fragments within free DNA,cou-pled with methylation analysis,contribute to the early diagnosis of tumors and provide guidance for treatment strategies.Following organ transplantation,circulating-free DNA emerges as a pivotal marker for immune rejection reaction surveillance,offering a novel vantage point for scrutinizing rejection mechanisms.This article reviews the sources,extraction methods,and detection methods of free DNA,and the progress of its research application in liver transplantation,hepatocellular carci-noma,and liver failure.

Free DNAHepatocellular carcinomaLiver transplantationInflammation

何粤川、帕成周、何玲华、陈刚

展开 >

650011 云南省昆明市第一人民医院/昆明医科大学附属甘美医院肝胆胰外科

游离DNA 肝癌 肝移植 炎性反应

云南省科技厅科技重大专项"春城计划"高层次创新创业团队专项

202302AA3100182022SCP002

2024

疑难病杂志
中国医师协会

疑难病杂志

CSTPCD
影响因子:1.171
ISSN:1671-6450
年,卷(期):2024.23(6)